Startups
Biotechnology / Funding / Investing / Science / Startups

This Rockville-based biotech startup nabbed a $2.5 million investment

Hememics Biotechnologies Inc. plans to use the investment from AMVI Partners to begin clinical research for FDA submission for its flagship biotech product, a point-of-care panel to test for sexually transmitted diseases.

Startups in the DMV region are advancing biotech products. (Photo by Pixabay user luvqs, used under a Creative Commons license)

Rockville, Maryland-based Hememics Biotechnologies Inc. has secured a $2.5 million investment from AMVI Partners, an international investment firm with offices in McLean, Virginia.

The startup is working on developing a handheld device equipped with a multiplex panel chip that is able to rapidly test a blood sample to detect bacteria or proteins in less than a minute. The initial device in development, named HEMEMICS, is a point-of-care panel to test for sexually transmitted diseases.

The company — one of the first of six health technology startups that the Northern Virginia-based Inova Health System invested in via its Inova Personalized Health Accelerator in 2017 — plans to use the investment to begin clinical research for a U.S. Food and Drug Administration submission for its flagship biotech product, it announced in a press release. Hememics connected with AMVI Partners through the Vietnamese American Business Council (VABC), a nonprofit based in McLean, Virginia, which has a mission to foster business opportunities between Vietnam and the U.S.

“Our long-term relationship with VABC has made this progress possible. This significant investment will enable us to achieve key milestones on our path to commercial availability,” said Hememics CSO and cofounder David Ho in a press release.

“We are thrilled to engage in this productive partnership with Vietnamese investors through AMVI Partners,” said Hememics CEO and cofounder John Warden in a statement. “Given the worldwide growth rates for STI such as chlamydia, gonorrhea and HPV, we are especially honored to have interest from the international investment community in our technology.”

The startup’s proprietary platform is protected by three patents, and the device doesn’t require refrigeration, according to its website. Here’s a visualization of how its technology works:

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

‘Racist rhetoric leads to attacks’: Asian Americans and lawsuit plaintiffs take on the TikTok ban

The US government is launching a new project to test and assess AI

A startup using AI to flag pathogens and contaminants just raised an $8.5M Series A

Inside Maryland’s latest effort to support emerging businesses

Technically Media